Which statement accurately describes the relationship between monitoring and the effectiveness of pharmacotherapy?

• A. Effectiveness is determined only by lab values
• B. Ongoing monitoring determines whether the medication is achieving the desired effect
• C. Monitoring is only required at initiation
• D. Monitoring should be avoided to prevent bias

Answer: (B)

Monitoring is how we know if a drug therapy is actually working and staying safe over time. Effectiveness isn’t shown by a single lab value alone; it’s about the overall clinical response, which includes patient symptoms, functional improvement, and whether any disease-specific targets are met. Ongoing monitoring collects this information repeatedly and guides decisions to adjust dose, change medications, or add therapies to reach the desired outcome while watching for adverse effects.

For example, anticoagulation is checked with an appropriate lab value (INR) to ensure it’s in the therapeutic range, blood pressure readings guide antihypertensives, glucose levels or HbA1c track diabetes meds, and symptom relief or objective improvements indicate effectiveness for many therapies. If monitoring shows the target response isn’t reached or safety concerns arise, therapy is adjusted accordingly.

The other statements fall short because lab values alone don’t capture the full therapeutic effect, monitoring isn’t limited to initiation, and deliberately avoiding monitoring would undermine care and bias decisions rather than prevent them.